The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia a pilot study

Journal of Clinical Psychopharmacology

Volumn 35, Issue 1, 2015, Pages 83-85

  Maia De Oliveira, Joao Paulo ^a,b,c   Abrao, Joao ^a   Evora, Paulo R ^a   Zuardi, Antonio W ^a,b   Crippa, Jose A S ^a,b   Belmonte De Abreu, Paulo ^b,d   Baker, Glen B ^b,e,f   Dursun, Serdar M ^b,e,f   Hallak, Jaime E C ^a,e  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^e UNIVERSITY OF ALBERTA   (Canada)

^f ALBERTA HOSPITAL EDMONTON   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; NITROPRUSSIDE SODIUM; PLACEBO; NITRIC OXIDE DONORS; NITROPRUSSIDE;

ALZHEIMER DISEASE; CARDIOVASCULAR EFFECT; COGNITIVE DEFECT; DEMOGRAPHY; DRUG EFFECT; EXECUTIVE FUNCTION; HUMAN; HYPERTENSION; LETTER; PILOT STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA; SECOND MESSENGER; SELECTIVE ATTENTION; STROOP TEST; TASK PERFORMANCE; WORKING MEMORY; COGNITION DISORDERS; CONTROLLED STUDY; DOUBLE-BLIND METHOD; DRUG EFFECTS; FEMALE; HUMANS; MALE; PILOT PROJECTS; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

COGNITION DISORDERS; DOUBLE-BLIND METHOD; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PILOT PROJECTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STROOP TEST; TREATMENT OUTCOME;

EID: 84925615140     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000258     Document Type: Letter

References (13)

1. Hallak JE, Maia-de-Oliveira JP, Abrao J, et al. Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside. JAMA Psychiatry. 2013;70:668-676.
2. Liddle PF, Morris DL. Schizophrenic syndromes and frontal lobe performance. Br J Psychiatry. 1991;158:340-345.
3. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643-662.
4. Gevins A, Cutillo B. Spatiotemporal dynamics of component processes in human working memory. Electroencephalogr Clin Neurophysiol. 1993;87:128-143.
5. Bredt DS, Snyder SH. Nitric oxide, a novel neuronal messenger. Neuron. 1992;8:3-11.
6. Segovia G, Mora F. Role of the nitric oxide in modulating the release of dopamine, glutamate, and GABA in striatum of the freely moving rat. Brain Res Bull. 1998;45:275-279.
7. Holscher C. Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity. Trends Neurosci. 1997;20:298-303.
8. Hindley S, Juurlink BH, Gysbers JW, et al. Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism. J Neurosci Res. 1997;47:427-439.
9. Paul V, Reddy L, Ekambaram P. A reversal by L-arginine and sodium nitroprusside of ageing-induced memory impairment in rats by increasing nitric oxide concentration in the hippocampus. Indian J Physiol Pharmacol. 2005;49:179-186.
10. Thatcher GA, Bennett BM, Revnolds JN. Nitric oxide mimetic molecule as therapeutic agents in Alzheimer's disease. Curr Alzheimer Res. 2005;2:171-182.
11. Garthwaite J, Boulton CL. Nitric oxide signaling in the nervous system. Annu Rev Physiol. 1995;57:683-706.
12. Miyamoto S, Miyake N, Jarskog LF, et al. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. Mol Psychiatry. 2012;17:1206-1227.
13. Velligan DI, Mahurin RK, Diamond PL, et al. The functional significance of symptomatology and cognitive function in schizophrenia. Schizophr Res. 1997;25:21-31.